Correction: c-Src activation mediates erlotinib resistance in head and neck cancer by stimulating c-Met (Clinical Cancer Research (2013) 19, (380-392))

L. P. Stabile, G. He, V. W. Lui, S. Thomas, C. Henry, C. T. Gubish, S. Joyce, K. M. Quesnelle, J. M. Siegfried, Grandis

Research output: Contribution to journal › Comment/debate › peer-review

Fingerprint

Dive into the research topics of 'Correction: c-Src activation mediates erlotinib resistance in head and neck cancer by stimulating c-Met (Clinical Cancer Research (2013) 19, (380-392))'. Together they form a unique fingerprint.